Evidence map›Paper›PMID 40710639›Full record

ArticleGels (Basel, Switzerland)2025

Three-Dimensional Printing and Supercritical Technologies for the Fabrication of Intricately Structured Aerogels Derived from the Alginate-Chitosan Polyelectrolyte Complex.

Natalia Menshutina, Andrey Abramov, Eldar Golubev, Pavel Tsygankov

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Natalia MenshutinaDepartment of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia.ORCID 0000-0001-7806-1426
Andrey AbramovDepartment of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia.
Eldar GolubevDepartment of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia.
Pavel TsygankovDepartment of Chemical and Pharmaceutical Engineering, Mendeleev University of Chemical Technology of Russia, Miusskaya pl. 9, 125047 Moscow, Russia.

Funding

Russian Science Foundation 23-73-01216
6 · The paper itself

Abstract

Patient-specific scaffolds for tissue and organ regeneration are still limited by the difficulty of simultaneously shaping complex geometries, preserving hierarchical porosity, and guaranteeing sterility. Additive technologies represent a promising approach for addressing problems in tissue engineering, with the potential to develop personalized matrices for the growth of tissue and organ cells. The utilization of supercritical technologies, encompassing the processes of drying and sterilization within a supercritical fluid environment, has demonstrated significant opportunities for obtaining highly effective matrices for cell growth based on biocompatible materials. We present a comprehensive methodology for fabricating intricately structured, sterile aerogels based on alginate-chitosan polyelectrolyte complexes. The target three-dimensional macrostructure is achieved through (i) direct ink writing or (ii) heterophase printing, enabling the deposition of inks with diverse rheological profiles (viscosities ranging from 0.8 to 2500 Pa·s). A coupled supercritical carbon dioxide drying-sterilization regimen at 120 bar and 40 °C is employed to preserve the highly porous architecture of the printed constructs. The resulting aerogels exhibit 96 ± 2% porosity, a BET surface area of 108-238 m

Indexed as

aerogeldirect ink writingheterophase systemsupercritical processsupercritical sterilization

Identifiers

PMID40710639
PMCPMC12294165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.